Self-harm Behaviour Among the Most At-risk Adolescents
Key facts
- Who runs it
- University of Ljubljana, Faculty of Medicine
- Where
- Slovenia2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 23 Mar 2023
- Planned end
- Oct 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3
- Columbia Suicide Severity Rating Scale (CSSRS)
- The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT)
- Experiences in Close Relationships-Relationship Structures (ECR-RS)
- Trauma Symptom Checklist for Children (TSCC)
- Personality Assessment Inventory-Adolescent (PAI-A)
- Inventory Of Statements About Self-Injury; ISAS
- The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0
- Borderline Personality Features Scale, BPFSC-11
- Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV)
- Adolescent Self-Harm Risk Scale; ASHRS
- Lifetime Incidence of Traumatic Events questionnaire (LITE)
- Genetic methods
- Record updated
- 28 March 2025
Who can take part
- Age
- 13 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Suicidality
- Self-harming with no intention to die
- Age 13-19
Who cannot take part
- Confirmed acute psychotic disorder
- Severe physical illness (e.g. cardiovascular or renal disease)
- Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
- Known mental disorder (e.g. depression, bipolar disorder, schizophrenia, intellectual disability)
- Severe physical illness (e.g. cardiovascular or renal disease)
- Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
- Mental disorder, history of suicidality or self-injurious behaviour in a first-degree relative (a parent or a sibling)
- Intellectual disability
- Acute poisoning (including with psychoactive substances); CONTROL GROUP:
- Suicidality
- Self-harming with no intention to die
- Acute poisoning (including with psychoactive substances)
Other criteria
- CLINICAL GROUP:
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 13 and 18 years old?
This trial is currently available in Slovenia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In the proposed study, three objectives will be pursued:
Read full original descriptionShow less
1. To develop a method to identify more effectively the acute and long-term risk of adolescents with the most threatening self-harm behaviours. 2. To identify the factors that influence the risk of self-harm behaviours and the success of treatment/treatment of these behaviours in the most at-risk adolescents (changes in these factors). 3. Develop guidelines for more effective treatment of the most at-risk adolescents.
For this purpose, a sample of approximately 200 young people who will be hospitalised for suicide risk (the most at risk in Slovenia) and an approximately equal number of healthy adolescents will be included. At inclusion, the presence of several factors will be assessed by reviewing demographic data, clinical diagnosis, self-assessment questionnaires and clinical psychological tests (CSSRS, B-NSSI-AT, ISAS, LPFS-BF2.0, BPFSC-11, TSCC, PAI, ECR-RS, DASA-YV, ASHRS), social assessment, and blood sampling for genetic analyses (DNA isolation, sequencing, nucleotide sequence recognition, quantification and evaluation of short tandem repeats, identification of methylation sites). Longitudinal tracking of autoaggressive events and heteroaggressive events during hospitalisation will be performed and recorded on an ongoing basis. The risk and protective factors of the adolescents most at risk will be compared with a control group of adolescents. The same factors will be reassessed in the most at-risk adolescents after 6 and 18 months of treatment as usual. The data will be collected in a data entry and storage system that will ensure the privacy of the data entered in accordance with the GDPR.
This will allow the investigators to identify young people at particular risk of severe self-harm behaviour more reliably, to target them for more intensive and effective treatment, and thus to improve their safety, quality of life and prognosis in the short and long term.
The 2 groups in the trial
- Patients
The Enrollment Kit and Time1 Kit will be administered at enrollment, Time2 Kit will be administered before discharge and Time 3 kit after 6 and 18 months post hospitalization (see Detailed description and Study Protocol). The interventions will be Treatment as usual.
Treatment: Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3, Columbia Suicide Severity Rating Scale (CSSRS), The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT), Experiences in Close Relationships-Relationship Structures (ECR-RS), Trauma Symptom Checklist for Children (TSCC), Personality Assessment Inventory-Adolescent (PAI-A), Inventory Of Statements About Self-Injury; ISAS, The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0, Borderline Personality Features Scale, BPFSC-11, Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV), Adolescent Self-Harm Risk Scale; ASHRS, Lifetime Incidence of Traumatic Events questionnaire (LITE), and Genetic methods
- Controls
The Enrollment Kit and the Time Kit1 will be administered (see Detailed description and Study Protocol).
Treatment: Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3, Columbia Suicide Severity Rating Scale (CSSRS), The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT), Experiences in Close Relationships-Relationship Structures (ECR-RS), Trauma Symptom Checklist for Children (TSCC), Personality Assessment Inventory-Adolescent (PAI-A), Inventory Of Statements About Self-Injury; ISAS, The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0, Borderline Personality Features Scale, BPFSC-11, Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV), Adolescent Self-Harm Risk Scale; ASHRS, Lifetime Incidence of Traumatic Events questionnaire (LITE), and Genetic methods
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents
- Criteria questions
- Built from NCT05765864, who can take part
- Record updated
- 28 March 2025